|
Volumn 280, Issue 7492, 2008, Pages 283-286
|
Update on asthma management
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE PLUS FORMOTEROL;
CLENIL MODULITE;
CORTICOSTEROID;
CYCLOSPORIN A;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FORMOTEROL;
GOLD;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
METHOTREXATE;
OMALIZUMAB;
PLACEBO;
SALBUTAMOL;
SALMETEROL;
STEROID;
TERBUTALINE;
THEOPHYLLINE;
UNCLASSIFIED DRUG;
ADD ON THERAPY;
ALLERGIC ASTHMA;
ARTICLE;
ASTHMA;
BRONCHOSPASM;
CLINICAL TRIAL;
DISEASE CONTROL;
DRUG DELIVERY SYSTEM;
DRUG DOSE INCREASE;
DRUG MEGADOSE;
EVENING DOSAGE;
HUMAN;
INHALER;
METERED DOSE INHALER;
MORNING DOSAGE;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PHARMACEUTICAL CARE;
PHARMACIST;
SELF CARE;
TREATMENT INDICATION;
TREATMENT PLANNING;
UNITED KINGDOM;
|
EID: 40749134109
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (7)
|